$XBI $141.20 +4.5% 📈
Want to access our searchable database of catalysts and more? Get access to BiopharmIQ for 30 days free, no credit card required. Check it out here!
$VBIV +3% initiates enrollment in ph 1/2 study of prophylactic COVID-19 vaccine VBI-2902. source
$SAVA +16% Entered into drug supply agreement with Evonik Industries AG for simulfam. source
$DRRX +5% Publication of DUR-928's mechanism of action in The Journal of Lipid Research. source
$PCRX +1% Reported preliminary unaudited sales of Exparel for Feb 2021 of $35M. source
$JNCE -5% Offering
$XENE -4% Offering